Drug Patent Expirations in September 2015

Drug Patent Expirations for September 2015

Tradename Applicant Generic Name Patent Number Patent Expiration
DENAVIR Denco Asset penciclovir sodium 5,840,763 Sep 1, 2015
DENAVIR Denco Asset penciclovir sodium 5,916,893 Sep 1, 2015
INTEGRILIN Schering eptifibatide 5,807,825 Sep 15, 2015
DEPODUR Pacira Pharms Inc morphine sulfate 5,807,572 Sep 15, 2015
SOMAVERT Pharmacia And Upjohn pegvisomant 6,057,292 Sep 21, 2015
DIPRIVAN Fresenius Kabi Usa propofol 5,731,355*PED Sep 22, 2015
DIPRIVAN Fresenius Kabi Usa propofol 5,731,356*PED Sep 22, 2015
DIPRIVAN Fresenius Kabi Usa propofol 5,714,520*PED Sep 22, 2015
DIPRIVAN Fresenius Kabi Usa propofol 5,908,869*PED Sep 22, 2015
KETEK Sanofi Aventis Us telithromycin D459798 Sep 24, 2015
VALCYTE Hoffmann La Roche valganciclovir hydrochloride 6,083,953*PED Sep 29, 2015
DEXFERRUM Luitpold iron dextran 5,624,668 Sep 29, 2015
MYCAMINE Astellas micafungin sodium 6,265,536 Sep 29, 2015
SYMLIN Astrazeneca Ab pramlintide acetate 5,814,600 Sep 29, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.
Click here for reuse options!
Copyright 2015 Biotechblog

Comments are closed.

%d bloggers like this: